Experts expressed concerns that the mutations could effect the efficacy of existing COVID-19 vaccines and therapeutics. However, "we have no data to believe that these mutations will have any impact on the effectiveness of vaccines now in use," said Peter Mohler, a co-author of the study and chief scientific officer at the Ohio State Wexner Medical Center and vice dean for research at the College of Medicine, in a statement.